1-14 of 14
Patrick F. Fogarty
Close
Sort by
Journal Articles

Multiyear, Real-World, Retrospective Cohort Study Using a Patient-Centric Approach to Evaluate the Burden of Hemophilia B in the United States

Priya Patel, Yong Chen, Arianna Burton, Jose Alvir, Darren Kailung Jeng, Anna Stachel, Jiayin Xue, Emily Cibelli, Patrick F. Fogarty
Journal: Blood
Blood (2022) 140 (Supplement 1): 13136–13137.
https://doi.org/10.1182/blood-2022-162618
Published: 2022
Journal Articles

Analysis of US Claims Real World Data of Hemophilia a & B Patients: Units Dispensed & Expenditures Associated with Utilization of and Switching from Standard to Extended Half-Life Factor Products

Bartholomew J. Tortella, MD MBA, Amit Chhabra, MBBS, MPH, José Alvir, DrPH, Emily R. Rubinstein, MPH, Lisa J. Young, MSc, Patrick F. Fogarty, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3508.
https://doi.org/10.1182/blood-2018-99-119133
Published: 2018
Journal Articles

Real-World Expenditures Associated with Treatment of Hemophilia a and B Patients with Standard and Extended Half-Life Factor Replacement Products in the US

Amit Chhabra, MBBS, MPH, José Alvir, DrPH, Dean Spurden, PhD, Patrick F. Fogarty, MD, Bartholomew Tortella, MDMBA, Margaret McDonald, PhD, Andreas M Pleil, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2351.
https://doi.org/10.1182/blood.V130.Suppl_1.2351.2351
Published: 2017
Journal Articles

Characterization of Bleeding in Hemophilia Carriers and Comparison to Women with Type 1 Von Willebrand Disease, Type 3 Von Willebrand Disease Obligate Carriers and Controls

Natasha Amrita Satkunam, MBBS, MSc, Johnny Mahlangu, MD, Christoph Bidlingmaier, MD PD, Dr. MD, Maria Eva Mingot-Castellano, PhD, Meera B. Chitlur, MD, Patrick F. Fogarty, MD, Adam Cuker, MD MS, Maria Elisa Mancuso, MD PhD, Pal André Holme, PhD MD, Julie Grabell, BA, CCRP, Wilma Hopman, MA, Prasad Mathew, MD, Paula D. James, MD
Journal: Blood
Blood (2016) 128 (22): 875.
https://doi.org/10.1182/blood.V128.22.875.875
Published: 2016
Journal Articles

Real World Data Analysis of Coagulation Factor IX Costs in Specific Patients with Hemophilia B Switching from Standard Half-Life to Extended Half-Life Products

Bartholomew J. Tortella, MD MBA, Patrick F. Fogarty, José Alvir, Margaret McDonald, Dean Spurden, Andreas M. Pleil, PhD
Journal: Blood
Blood (2016) 128 (22): 4963.
https://doi.org/10.1182/blood.V128.22.4963.4963
Published: 2016
Journal Articles

Knowledge Gaps in the Management of Hemophilia Among Hematologists/Oncologists

Emily S Van Laar, MS, Charlotte Warren, Jayashri Desai, Patrick F. Fogarty, MD
Journal: Blood
Blood (2014) 124 (21): 4831.
https://doi.org/10.1182/blood.V124.21.4831.4831
Published: 2014
Journal Articles

A Cross-Sectional Analysis of Cardiovascular Disease in the Hemophilia Population

Suman L. Sood, MD, Dunlei Cheng, PhD, Amy D Shapiro, Craig M. Kessler, MD, Nigel S. Key, MBChB, Doris V. Quon, MD PhD, M. Elaine Eyster, MD, Marilyn J. Manco-Johnson, MD, Christine L. Kempton, MD, Patrick F. Fogarty, MD, Margaret V. Ragni, MD MPH, Joan Cox Gill, MD, Philip Kuriakose, MD, Annette von Drygalski, MD PharmD, Peter A. Kouides, Miguel Antonio Escobar, MD, Anne T. Neff, MD, Tzu-Fei Wang, MD, Cindy A Leissinger, MD, Sarah Galdzicka, Barbara A. Konkle, MD
Journal: Blood
Blood (2014) 124 (21): 2836.
https://doi.org/10.1182/blood.V124.21.2836.2836
Published: 2014
Journal Articles

Revascularization Strategies and In-Hospital Outcomes In Acute Coronary Syndromes (ACS) Complicated By Von Willebrand Disease (VWD)

Patrick F. Fogarty, M.D., William H. Matthai, Jr., M.D., Anne Boccuti, B.A., Rolando Vega, B.A., Elaine Y Chiang, M.D., Phyllis A. Gimotty, Ph.D.
Journal: Blood
Blood (2013) 122 (21): 2354.
https://doi.org/10.1182/blood.V122.21.2354.2354
Published: 2013
Journal Articles

ITP: Tolerance Lost

Patrick F. Fogarty
Journal: Blood
Blood (2011) 118 (24): 6232–6234.
https://doi.org/10.1182/blood-2011-10-383893
Published: 2011
Journal Articles

Survey of Current Prophylaxis Practices and Bleeding Characteristics of Children with Severe Hemophilia A In U.S. Hemophilia Treatment Centers.

Margaret V. Ragni, MD, MPH, Patrick F. Fogarty, MD, Neil C. Josephson, MD, Anne T. Neff, MD, Leslie Raffini, MD, Craig M. Kessler, MD
Journal: Blood
Blood (2010) 116 (21): 3653.
https://doi.org/10.1182/blood.V116.21.3653.3653
Published: 2010
Journal Articles

Hemostatic Challenges In Patients Treated with Eltrombopag

Michael D. Tarantino, MD, Patrick F. Fogarty, MD, Bhabita Mayer, MSc, Sandra Y. Vasey, MS, Andres Brainsky, MD
Journal: Blood
Blood (2010) 116 (21): 2511.
https://doi.org/10.1182/blood.V116.21.2511.2511
Published: 2010
Journal Articles

Efficacy of Eltrombopag In Splenectomized Versus Nonsplenectomized Patients with Chronic ITP In the RAISE Study

Harold J. Olney, MD, CM, FRCP (C), Patrick F. Fogarty, MD, Michael D. Tarantino, MD, Bhabita Mayer, MSc, Sandra Y. Vasey, MS, Andres Brainsky, MD
Journal: Blood
Blood (2010) 116 (21): 2512.
https://doi.org/10.1182/blood.V116.21.2512.2512
Published: 2010
Journal Articles

Oral Eltrombopag Treatment Reduces the Need for Concomitant Medications in Patients with Chronic Idiopathic Thrombocytopenic Purpura.

Patrick F. Fogarty, James B Bussel, Gregory Cheng, Mansoor N Saleh, Balkis Meddeb, Christine Bailey, Andres Brainsky
Journal: Blood
Blood (2008) 112 (11): 3424.
https://doi.org/10.1182/blood.V112.11.3424.3424
Published: 2008
Journal Articles

High-dose cyclophosphamide with autologous lymphocyte–depleted peripheral blood stem cell (PBSC) support for treatment of refractory chronic autoimmune thrombocytopenia

Clinical Trials & Observations
Richard D. Huhn, Patrick F. Fogarty, Ryotaro Nakamura, Elizabeth J. Read, Susan F. Leitman, Margaret E. Rick, Janice Kimball, Adeira Greene, Kristin Hansmann, Alois Gratwohl, Neal Young, A. John Barrett, Cynthia E. Dunbar
Journal: Blood
Blood (2003) 101 (1): 71–77.
https://doi.org/10.1182/blood-2001-12-0171
Published: 2003